Drugs Information:
Anagrelide
Basic Information
|
||
ID | DDInter93 | |
Drug Type | small molecule | |
Molecular Formula | C10H7Cl2N3O | |
Molecular Weight | 256.088 | |
CAS Number | 68475-42-3 | |
Description | Anagrelide is a platelet-reducing agent used to lower dangerously elevated platelet levels (i.e. to treat thrombocythemia) in patients with myeloproliferative neoplasms.[L14153] It is an oral imidazoquinazoline that was first approved for use in the US in 1997.[A214274] It appears to carry a better response rate than other thrombocythemia treatments (e.g. [busulfan], [hydroxyurea]) and may be better tolerated.[A214274] | |
ATC Classification | L01XX35 | |
IUPAC Name | 6,7-dichloro-1H,2H,3H,5H-imidazo[2,1-b]quinazolin-2-one | |
InChI | OTBXOEAOVRKTNQ-UHFFFAOYSA-N | |
Canonical SMILES | ClC1=CC=C2N=C3NC(=O)CN3CC2=C1Cl | |
Useful Links | DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider BindingDB PharmGKB Therapeutic Targets Database Wikipedia ChEMBL ZINC |
Interactions with
Anagrelide
Filter:
Severity level | ID | Name | Mechanism | Detail |
---|
Interactions with diseases
Filter:
Severity level | Disease name | Text | References |
---|
Interactions with foods
Filter:
Severity level | Food name | Description | Management | Mechanism | References |
---|
Interactions with compound preparation
Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
---|